{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:25:47Z","timestamp":1790871947140,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01271","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:24:16Z","timestamp":1528244656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Myeloid-Derived Suppressor Cells Specifically Suppress IFN-\u03b3 Production and Antitumor Cytotoxic Activity of V\u03b42 T Cells"],"prefix":"10.3389","volume":"9","author":[{"given":"Alessandra","family":"Sacchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Casetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Agrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","article-title":"Gamma delta cells: a right time and a right place for a conserved third way of protection","volume":"18","author":"Hayday","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1073\/pnas.91.17.8175","article-title":"Non peptide ligands for human gamma delta T cells","volume":"91","author":"Tanaka","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/375155a0","article-title":"Natural and synthetic non-peptide antigens recognized by human gamma delta T cells","volume":"375","author":"Tanaka","year":"1995","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","article-title":"Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs","volume":"285","author":"Jomaa","year":"1999","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.4049\/jimmunol.167.11.6195","article-title":"Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on\/off\/on cycling pattern in response to live bacterial products","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","article-title":"Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human gammadelta T Cells","volume":"309","author":"Brandes","year":"2005","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00262-011-1021-7","article-title":"Phase I\/II study of adoptive transfer of \u03b3\u03b4 T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma","volume":"60","author":"Kobayashi","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.4049\/jimmunol.175.8.5481","article-title":"V gamma 9V delta 2 T cell response to colon carcinoma cells","volume":"175","author":"Corvaisier","year":"2005","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.it.2012.01.006","article-title":"Harnessing \u03b3\u03b4 T cells in anticancer immunotherapy","volume":"33","author":"Hannani","year":"2012","journal-title":"Trends Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1097\/QAD.0000000000000871","article-title":"In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3\u03b6 expression through ELF-1 inhibition","volume":"29","author":"Tumino","year":"2015","journal-title":"AIDS"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1128\/JVI.01759-12","article-title":"Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals","volume":"87","author":"Qin","year":"2013","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/scitranslmed.aae0482","article-title":"Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus","volume":"8","author":"Wu","year":"2016","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1038\/s41598-018-21856-2","article-title":"Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice","volume":"8","author":"Park","year":"2018","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1189\/jlb.5VMR1116-458RRR","article-title":"Myeloid-derived suppressor cells \u2013 a new therapeutic target to overcome resistance to cancer immunotherapy","volume":"102","author":"Chesney","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e22892","DOI":"10.4161\/onci.22892","article-title":"Tumor cell recognition by \u03b3\u03b4 T lymphocytes","volume":"2","author":"Correia","year":"2013","journal-title":"Oncoimmunology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.4049\/jimmunol.177.8.5290","article-title":"CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production","volume":"177","author":"Caccamo","year":"2006","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/eji.200636220","article-title":"gammadelta T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis","volume":"36","author":"Caccamo","year":"2006","journal-title":"Eur J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2249.1996.d01-625.x","article-title":"Gamma delta T lymphocyte responses to HIV","volume":"103","author":"Wallace","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e100350","DOI":"10.1371\/journal.ppat.1003501","article-title":"Phosphoantigen\/IL2 expansion and differentiation of V\u03b32V\u03b42 T cells increase resistance to tuberculosis in nonhuman primates","volume":"9","author":"Chen","year":"2013","journal-title":"PLoS Pathog"},{"key":"B25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.24700","article-title":"Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species","volume":"55","author":"Tacke","year":"2012","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0123772","DOI":"10.1371\/journal.pone.0123772","article-title":"Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level","volume":"10","author":"El Daker","year":"2015","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"21137","DOI":"10.18632\/oncotarget.4121","article-title":"A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model","volume":"6","author":"Guo","year":"2015","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:24:21Z","timestamp":1528244661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,6]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2018.01271"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01271","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,6]]},"article-number":"1271"}}